ELEM Biotech

elem.bio LinkedIn

ELEM Biotech simulates human physiology, building virtual patients that drug and device makers can test against instead of running an early trial.

Industry

Health (Digital, Devices, Medtech, Pharma & Biotech)

Company size

11-50

In Barcelona

11-50

Founded

2018

AI highlights Public evidence, checked Sep 2026

Product ELEM biosimulation technology combines clinical data, mechanistic modelling, physics-based simulation and AI-driven analytics to generate quantitative predictions across drug discovery, safety assessment and clinical development.. Describes its own product as AI on its own site: "ai-driven" Sep 2026 ↗ Product ELEM Technology is developed by senior engineers and domain scientists with expertise in computational modelling, QSP/PBPK methodologies, medical informatics and AI, for Model Informed Drug Development.. Describes its own product as AI on its own site: "ai" Sep 2026 ↗ Publication What happens when we overdose loperamide? A cardiac safety trial powered by AI and mechanistic models Elem Biotech, Barcelona, Spain Aug 2026 ↗

At the campus

No sessions with ELEM Biotech are planned yet.

Want to hear from them? Tell us what you would like them to talk about and we will ask.

I want to hear from them